In-vitro activity of 3-azinomethyl-rifamycin (SPA-S-565) against Chlamydia trachomatis

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 2, 1996, Pages 357-359

  Zanetti, S ^a   Usai, D ^a   Nonis, A ^b   Fadda, G ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Società Prodotti Antibiotici   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(1 DIETHYLAMINOETHYLIDENE)AZINOMETHYL]RIFAMYCIN SV; ERYTHROMYCIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CHLAMYDIA TRACHOMATIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; CHLAMYDIA TRACHOMATIS; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; RIFAMPIN; RIFAMYCINS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 0029916479     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.2.357     Document Type: Article

References (7)

1. Carta, F., Zanetti, S., Pinna, A., Sotgiu, M. & Fadda, G. (1994). The treatment and follow up of adult chlamydial ophthalmia, British Journal of Ophthalmology 78, 206-8.
2. Jones, R. B., Ridgway, G. L., Boulding, S. & Hunley, K. L. (1983). In-vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis. Reviews of Infectious Diseases 5, Suppl. 3, 556-61.
3. Jones, R. B., Van Der Pol, B., Martin, D. H. & Shepard, M. K. (1990). Partial characterisation of Chlamydia trachomatis isolates resistant to multiple antibiotics. Journal of Infectious Diseases 162, 1309-15.
4. Strippoli, V., Bruzzese, T , Galli, R., Simonetti, N. & Tronci, N. (1988). The antibacterial activity of a new 3-azinomethyl-rifamycin. Farmaco-Edizione Scientifica 43, 619-25.
5. Thompson, S. E. & Washington, A. E. (1983). Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiology Review 5, 96-123.
6. Yearsley, P. J., Treharme, J. D. & Ballard, R. C. (1988). Emergence of resistance to rifampicin and rifabutin in C. trachomatis. In the Proceedings of the First European Society for Chlamydia Research, Bologna, Italy, 1988.
7. Zanetti, S., Ungheri, D., Castellani Pastoris, M. & Fadda, G. (1987). Comparative in-vitro susceptibility studies of FCE 22250 and rifampicin on Letionella and Chlamydia trachomatis strains. Drugs Under Experimental and Clinical Research (Geneva) 13, 631-4.